Investigation of cardiac adverse effects in COVID-19 ARDS patients treated with intravenous immunoglobulin
Description
CONCLUSION: Our study suggests that IVIG therapy may be used safely in COVID-19 patients with cardiovascular side effects. However, due to the high risk of coagulopathy in these patients, the use of IVIG therapy in COVID-19 infection should be